Shandong Wohua Pharmaceutical Co., Ltd. (SHE:002107)
China
· Delayed Price · Currency is CNY 6.93
-0.07 (-1.00%)
Mar 11, 2026, 10:25 AM CST
SHE:002107 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 95.72 | 36.4 | 58.77 | 107.39 | 163.39 | Upgrade
|
| Depreciation & Amortization | 31.51 | 32.47 | 33.22 | 35.33 | 33.05 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -0.07 | -2.15 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.17 | 0.03 | 0.06 | 0.44 | 13.56 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.76 | - | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 0.34 | -1.02 | -1.96 | 1.72 | -0.91 | Upgrade
|
| Other Operating Activities | -8.36 | 1.56 | -9.07 | -12.36 | 5.07 | Upgrade
|
| Change in Accounts Receivable | 3.3 | 28.14 | 50.32 | -40.84 | 63.28 | Upgrade
|
| Change in Inventory | 11.72 | 40.65 | -5.36 | 15.49 | -53.83 | Upgrade
|
| Change in Accounts Payable | -4.31 | -46 | 2.63 | 78.07 | -24.82 | Upgrade
|
| Operating Cash Flow | 128.53 | 91.51 | 129.25 | 185.26 | 200.12 | Upgrade
|
| Operating Cash Flow Growth | 40.45% | -29.20% | -30.23% | -7.43% | 1.80% | Upgrade
|
| Capital Expenditures | -0.86 | -3.82 | -2.72 | -6.77 | -19.08 | Upgrade
|
| Sale of Property, Plant & Equipment | 14.65 | 0.03 | 0.09 | 1.16 | - | Upgrade
|
| Divestitures | 0.82 | - | - | - | - | Upgrade
|
| Other Investing Activities | - | 0.19 | - | - | - | Upgrade
|
| Investing Cash Flow | 14.61 | -3.6 | -2.62 | -5.6 | -19.08 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 0.28 | - | Upgrade
|
| Total Debt Issued | - | - | - | 0.28 | - | Upgrade
|
| Long-Term Debt Repaid | -1.14 | -0.35 | -0.61 | -0.24 | -188.84 | Upgrade
|
| Total Debt Repaid | -1.14 | -0.35 | -0.61 | -0.24 | -188.84 | Upgrade
|
| Net Debt Issued (Repaid) | -1.14 | -0.35 | -0.61 | 0.04 | -188.84 | Upgrade
|
| Common Dividends Paid | -69.27 | -144.3 | - | -150.07 | -154.86 | Upgrade
|
| Other Financing Activities | -21.57 | - | -2.94 | -79.28 | - | Upgrade
|
| Financing Cash Flow | -91.97 | -144.65 | -3.55 | -229.32 | -343.69 | Upgrade
|
| Net Cash Flow | 51.16 | -56.74 | 123.07 | -49.67 | -162.65 | Upgrade
|
| Free Cash Flow | 127.66 | 87.69 | 126.53 | 178.49 | 181.04 | Upgrade
|
| Free Cash Flow Growth | 45.59% | -30.70% | -29.11% | -1.41% | 27.13% | Upgrade
|
| Free Cash Flow Margin | 15.63% | 11.48% | 13.91% | 17.59% | 19.20% | Upgrade
|
| Free Cash Flow Per Share | 0.23 | 0.14 | 0.21 | 0.32 | 0.31 | Upgrade
|
| Cash Interest Paid | - | - | 0.24 | 0.34 | 1.16 | Upgrade
|
| Cash Income Tax Paid | 111.89 | 99.58 | 134.26 | 138.53 | 140.6 | Upgrade
|
| Levered Free Cash Flow | 111.02 | 79.04 | 114.06 | 143.68 | 105.97 | Upgrade
|
| Unlevered Free Cash Flow | 111.06 | 79.05 | 114.08 | 143.69 | 108.9 | Upgrade
|
| Change in Working Capital | 10.92 | 22.07 | 48.29 | 54.9 | -14.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.